Join to view full profile
1001 Calumet AveDyer, IN 46311
Phone+1 219-924-8178
Fax+1 219-924-8179
Dr. Kassar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2004
Damascus University Faculty of MedicineClass of 1999
Certifications & Licensure
IN State Medical License 2007 - 2027
IL State Medical License 2005 - 2011
CT State Medical License 2004 - 2005
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification GeniusDoc, GeniusDoc, Inc., 2014-2017
- CMS Meaningful Use Stage 1 Certification GeniusDoc EHR, GeniusDoc, Inc., 2014-2017
- CMS Meaningful Use Stage 2 Certification iKnowMed Generation 2, McKesson, 2014-2017
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Publications & Presentations
PubMed
- 102 citationsRandomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta
Journal of Clinical Oncology. 2020-04-09 - 48 citationsMammaPrint guides treatment decisions in breast cancer: results of the IMPACt trial.Hatem Soliman, Varsha Shah, Gordan Srkalovic, Reshma Mahtani, Ellis G. Levine
BMC Cancer. 2020-01-31 - 17 citationsSafety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front...Reem Karmali, Mohamad Kassar, Parameswaran Venugopal, Jamile M. Shammo, Henry C. Fung
Clinical Lymphoma, Myeloma & Leukemia. 2011-12-01
Press Mentions
Powers Health, Northwest Cancer Centers Collaborate on Cancer Care Hub - Building Indiana BusinessDecember 1st, 2025- The US Oncology Network Continues to Grow, Enhancing Community Cancer Care by Welcoming Two More PracticesOctober 22nd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
